C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2007
12/21/2007	WO2004069848A3 Amidases, nucleic acids encoding them and methods for making and using them
12/21/2007	WO2003064613A3 Amidases, nucleic acids encoding them and methods for making and using them
12/21/2007	CA2836760A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007	CA2659676A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007	CA2657949A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses
12/21/2007	CA2655565A1 Dph2 gene deletion mutant and uses thereof
12/20/2007	US20070294786 Fructan Biosynthetic Enzymes
12/20/2007	US20070293450 Identification of ses-3 and the uses of same
12/20/2007	US20070293429 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity
12/20/2007	US20070293425 Mutein of a Bone Morphogenetic Protein and Use Thereof
12/20/2007	US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007	US20070292922 Regulated expression of recombinant proteins from adeno-associated viral vectors
12/20/2007	US20070292921 tRNA synthetases, metRS
12/20/2007	US20070292920 Neurotoxins with enhanced target specificity
12/20/2007	US20070292919 Composition and methods for improving the production of fermentation operations
12/20/2007	US20070292918 Codon optimization method
12/20/2007	US20070292917 Composition and methods for expressing reporter molecules in mammalian cells
12/20/2007	US20070292916 Mutant protein having the peptide-synthesizing activity
12/20/2007	US20070292915 Human OCT-2 Variant Peptide Chains, Nucleic Acids, and Methods
12/20/2007	US20070292914 Nucleic acid sequence encoding a polypeptide having acetohydroxy acid synthetase (AHAS) activity; fermentative production of branched-chain amino acids using these enzymes in specific hosts in which genes which code for the modified AHAS are expressed
12/20/2007	US20070292913 Novel Bacterial Expression System
12/20/2007	US20070292899 Method Of Protein Extraction From Cells
12/20/2007	US20070292898 Functional Screening Assay
12/20/2007	US20070292885 Human cdnas and proteins and uses thereof
12/20/2007	US20070292847 nucleic acid molecule encoding a protein that hydrolyzes cyclic adenosine mono-phosphate (cAMP); leishmaniasis
12/20/2007	US20070292845 Diagnostics, gene therapy
12/20/2007	US20070292840 Replication Competent Hepatitis C Virus and Methods of Use
12/20/2007	US20070292581 Lipoxygenase
12/20/2007	US20070292490 Production of tissue factor in plants
12/20/2007	US20070292449 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
12/20/2007	US20070292439 B cell-related cancers and solid tumors, and diseases or disorders that have an autoimmune and/or inflammatory component, including organ and tissue transplant rejection
12/20/2007	US20070292437 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
12/20/2007	US20070292432 Immunoglobulins
12/20/2007	US20070292426 Methods and compositions based on Shiga toxin type 1 protein
12/20/2007	US20070292424 Novel human eosinophil-derived basic protein
12/20/2007	US20070292420 For diagnosing or treating rheumatoid arthritis, osteoarthritis, osteolysis, aseptic loosening of orthopedic implants, lupus, type 2 diabetes, COPD, and renal cell carcinoma
12/20/2007	US20070292419 Treatment with anti-erbb2 antibodies
12/20/2007	US20070292416 De-Immunized Anti-Cd3 Antibody
12/20/2007	US20070292411 Antibodies That Immunospecifically Bind to TRAIL Receptors
12/20/2007	US20070292405 Uses of Erss Modulators
12/20/2007	US20070292346 Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk
12/20/2007	CA2635467A1 Bst2 inhibitor
12/19/2007	EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use
12/19/2007	EP1867720A2 Purified genes encoding mammalian cell surface antigens; proteins and antibodies
12/19/2007	EP1867659A1 Antibody reactive specifically to age derived from 3,4-dge
12/19/2007	EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins
12/19/2007	EP1558278A4 Production of homotrimeric fusion proteins
12/19/2007	EP1535999B1 Milk-coagulating enzyme originating in bacterium and process for producing cheese using the same
12/19/2007	EP1305435B1 Use of herpes simplex virus glycoprotein d to suppress immune responses
12/19/2007	EP1287014B1 Enhanced protein thermostability and temperature resistance
12/19/2007	EP1230369B1 Polypeptide hormone phosphatonin
12/19/2007	EP1179593B1 Process for producing recombinant insulin from novel fused protein
12/19/2007	EP0652950B1 Generation of xenogeneic antibodies
12/19/2007	EP0519001B2 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/19/2007	CN101090977A Tripeptide and tetrapeptide thioethers
12/19/2007	CN101090969A 鼠李糖启动子表达系统 Rhamnose promoter expression system
12/19/2007	CN101089188A Bacterial peptide-X purification technology
12/19/2007	CN101089181A Production method of recombination human interleukin-4
12/19/2007	CN101088561A Anti hepatitis c virus antibody and uses thereof
12/19/2007	CN100355950C Polypeptide random library and its construction method, and method for screening polypeptide capable of penetrating cell from the library
12/19/2007	CN100355903C Process for preparing oligomeric peptide capable of inhibiting angiotonase activity
12/19/2007	CN100355784C Method for preparing polyethylene glycol-modified alpha-interferon 1b
12/19/2007	CN100355783C Anti-coagulate protein and its coding gene and high effective expression method
12/18/2007	US7309780 Antibodies to natural killer cell activating factor II
12/18/2007	US7309778 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/18/2007	US7309777 Antibodies against the PRO1556 polypeptide
12/18/2007	US7309776 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
12/18/2007	US7309774 for drug screening enzyme inhibitors for making fibrin deposits or blood clots more susceptible to removal by plasmin; fluorescence resonance energy transfer (FRET); genetic engineering
12/18/2007	US7309771 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
12/18/2007	US7309768 PRO4347 polypeptides
12/18/2007	US7309767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
12/18/2007	US7309765 PRO4349 polypeptides
12/18/2007	US7309764 PRO4401 polypeptide
12/18/2007	US7309763 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
12/18/2007	US7309760 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
12/18/2007	US7309605 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
12/18/2007	US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
12/18/2007	US7309596 Amino acid sequence; protection of the plants against pathogens and predators; multi-proteinase inhibitor domains and will be useful in developing a range of transgenic plants with enhanced proteinase inhibitor expression
12/18/2007	US7309595 Comprises protease for use in generating proline rich protein hydrolysate for use in food and drink to decrease allergenicity, facilitate gastrointestinal uptake and to stabilize proteins in acid products against precipitation during prolonged storage
12/18/2007	US7309587 Process for producing β 1,3-N-acetylglucosaminyl-transferase and N-acetylglucosamine-containing complex carbohydrate
12/18/2007	US7309585 Protein, therapy, diagnosis of cancer, to elicit an immune response
12/18/2007	US7309584 Mutations of the MDR1 P-glycoprotein that improves its ability to confer resistance to chemotherapeutic drugs
12/18/2007	US7309583 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals
12/18/2007	US7309494 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus
12/18/2007	CA2235400C Cartilage/bone inducing materials for reparation
12/18/2007	CA2233042C Specific binding members for human transforming growth factor beta; materials and methods
12/18/2007	CA2062047C Fusion proteins for prodrug activation, the preparation and use thereof
12/18/2007	CA1341566C Immune response to tumors induced by anti-idiotype antibodies
12/13/2007	WO2007143104A2 Antibodies as t cell receptor mimics, methods of production and uses thereof
12/13/2007	WO2007143085A2 Collecting and analyzing surface wound data
12/13/2007	WO2007142711A2 Methods for diagnosing and treating cancer
12/13/2007	WO2007142277A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
12/13/2007	WO2007142258A1 Anthocyanin synthesis regulatory gene, and use thereof
12/13/2007	WO2007142243A1 Mutant and gene encoding the same
12/13/2007	WO2007140545A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore
12/13/2007	WO2007120932A9 Expression of o-glycosylated therapeutic proteins in prokaryotic microorganisms
12/13/2007	WO2007108559A8 Agonistic antibody directed against human thrombopoietin receptor
12/13/2007	WO2007084507A3 [ψ[CH2NH]PG4] GLYCOPEPTIDE ANTIBIOTIC ANALOGS
12/13/2007	WO2007067557A3 Methods for cyclic nucleotide determination
12/13/2007	WO2007046971A3 Antiepileptogenic complex of albumin with docosahexaenoate

1 ... 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 ... 1125